Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.

-
NVIDIA’s Josh Parker on How AI and Accelerated Computing Drive Sustainability – Ep. 234
From improving energy efficiency to helping address climate challenges, AI and accelerated computing are becoming key tools in the push for sustainability. In this episode of NVIDIA’s AI Podcast, Joshua Parker, senior director of corporate…
-
SonicJobs CEO Mikhil Raja on Using AI Agents to Connect the Internet, starting with Jobs – Ep. 233
Companies in the US spend $15bn annually on talent acquisition. The most important metric in recruitment advertising is the conversion from the paid click on the job platform to the application the employer receives. Industry-wide,…
-
Machina Labs’ Edward Mehr on Autonomous Blacksmith Bots and More – Ep. 232
Edward Mehr works where AI meets the anvil. The company he cofounded, Machina Labs, blends the latest advancements in robotics and AI to form metal into countless shapes for use in defense, aerospace, and more.…
-
Snowflake’s Baris Gultekin on Unlocking the Value of Data With Large Language Models – Ep. 231
Snowflake is using AI to help enterprises transform data into insights and applications. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz and Baris Gultekin, head of AI at Snowflake, discuss how the company’s…
-
Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI – Ep. 230
Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz…
-
How Georgia Tech’s AI Makerspace Is Preparing the Future Workforce for AI – Ep. 229
AI is set to transform the workforce — and the Georgia Institute of Technology’s new AI Makerspace is helping tens of thousands of students get ahead of the curve. In this episode of NVIDIA’s AI…
-
Paige Cofounder Thomas Fuchs’ Diagnosis on Improving Cancer Patient Outcomes With AI – Ep. 228
Improved cancer diagnostics — and improved patient outcomes — could be among the changes generative AI will bring to the healthcare industry, thanks to Paige, the first company with an FDA-approved tool for cancer diagnosis.…
-
How Roblox Uses Generative AI to Enhance User Experiences – Ep. 227
Roblox is a colorful online platform that aims to reimagine the way that people come together — now that vision is being augmented by generative AI. In this episode of NVIDIA’s AI Podcast, host Noah…
-
Michael Rubloff Explains How Neural Radiance Fields Turn 2D Images Into 3D Models – Ep. 226
Let’s talk about NeRFs — no, not the neon-colored foam dart blasters, but neural radiance fields, a technology that might just change the nature of images forever. In this episode of NVIDIA’s AI Podcast recorded…
-
Yotta CEO Sunil Gupta on Supercharging India’s Fast-Growing AI Market – Ep. 225
India’s AI market is expected to be massive. Yotta Data Services is setting its sights on supercharging it. In this episode of NVIDIA’s AI Podcast, Sunil Gupta, cofounder, managing director and CEO of Yotta Data…